Joan Armengol Alegre

Joan Armengol Alegre

Auto-generated profile, based on publicly available information

Joan Armengol Alegre

Institut Català de la Salut

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
CRCarol Rovira
Carol Rovira
PMPilar Modamio
Pilar Modamio
JPJoaquim Pascual
Joaquim Pascual
JAJoan Armengol
Joan Armengol
CACristian Ayala
Cristian Ayala
ARAnna Ramirez
Anna Ramirez
Introduction The increase in elderly population has led to an associated increase in multiple pathologies, frailty, polypharmacy, healthcare costs, decreased quality of life and mortality. We designed an intervention based on person-centred care model. This article outlines a study protocol, which aims to explore the effects of the intervention to improve therapeutic adequacy in polymedicated elderly patients. Methods and analysis An open, randomised, multicentre, controlled clinical trial. The study population includes polymedicated (≥8 prescription medications) patients ≥75 years old. In the intervention group, the multidisciplinary team (primary care pharmacist, family doctor and nurse) will meet to carry out multidimensional reviews (frailty, clinical complexity, morbidity and therapeutic adequacy) of the study subjects. If changes are proposed to the treatment plan, a clinical interview will be conducted with the patient to agree on changes in accordance with their preferences. Follow-up visits will be scheduled at 6 and 12 months. In the control group, where the usual clinical practice will be followed, the necessary data will be collected to compare the results. The key variables are the variation in the mean number of incidents (potentially inappropriate prescription) per patient, the number of medications, the number of changes implemented to the treatment plan and the variation in the number of hospital admissions. Ethics and dissemination This study was approved by the Ethics Committee of the IDIAPJGol and by the University of Barcelona’s Bioethics Commission. The results are expected to be published in peer reviewed open-access journals, and as part of a doctoral thesis. Trial registration number NCT04188470. Pre-results.

7 April 2025 in JMIR Research Protocols
Verified
Journal Article
Open access
Josep Vidal-AlaballJosep Vidal-Alaball
Josep Vidal-Alaball
CACarlos Alonso
Carlos Alonso
DHDaniel Hugo Heinisch
Daniel Hugo Heinisch
ACAlberto Castaño
Alberto Castaño
ESEncarna Sánchez-Freire
Encarna Sánchez-Freire
AGAnna Gomez-Fernandez
Anna Gomez-Fernandez
Background: Relisten is an artificial intelligence (AI)–based software developed by Recog Analytics that improves patient care by facilitating more natural interactions between health care professionals and patients. This tool extracts relevant information from recorded conversations, structuring it in the medical record, and sending it to the Health Information System after the professional’s approval. This approach allows professionals to focus on the patient without the need to perform clinical documentation tasks. Objective: This study aims to evaluate patient-reported satisfaction and perceived quality of care, assess health care professionals’ satisfaction with the care provided, and measure the time spent on entering records into the electronic medical record using this AI-powered solution. Methods: This proof-of-concept (PoC) study is conducted as a multicenter trial with the participation of several health care professionals (nurses and physicians) in primary care centers (CAPs). The key outcome measures include (1) patient-reported quality of care (evaluated through anonymous surveys), (2) health care professionals’ satisfaction with the care provided (assessed through surveys and structured interviews), and (3) time saved on clinical documentation (determined by comparing the time spent manually writing notes versus reviewing and correcting AI-generated notes). Statistical analyses will be performed for each objective, using independent sample comparison tests according to normality evaluated with the Kolmogorov-Smirnov test and Lilliefors correction. Stratified statistical tests will also be performed to consider the variance between professionals. Results: The protocol has been developed using the SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) checklist. Recruitment began in July 2024, and as of November 2024, a total of 318 patients have been enrolled. Recruitment is expected to be completed by March 2025. Data analysis will take place between April and May 2025, with results expected to be published in June 2025. Conclusions: We expect an improvement in the perceived quality of care reported by patients and a significant reduction in the time spent taking clinical notes, with a saving of at least 30 seconds per visit. Although a high quality of the notes generated is expected, it is uncertain whether a significant improvement over the control group, which is already expected to have high-quality notes, will be demonstrated. Trial Registration: ClinicalTrials.gov NCT06618092; https://clinicaltrials.gov/study/NCT06618092 International Registered Report Identifier (IRRID): DERR1-10.2196/66232

16 September 2024 in JMIR Preprints
Verified
Preprint
Open access
Josep Vidal-AlaballJosep Vidal-Alaball
Josep Vidal-Alaball
CACarlos Alonso
Carlos Alonso
DHDaniel Hugo Heinisch
Daniel Hugo Heinisch
ACAlberto Castaño
Alberto Castaño
ESEncarna Sánchez-Freire
Encarna Sánchez-Freire
AGAnna Gomez-Fernandez
Anna Gomez-Fernandez
BACKGROUND Relisten is an artificial intelligence (AI)–based software developed by Recog Analytics that improves patient care by facilitating more natural interactions between health care professionals and patients. This tool extracts relevant information from recorded conversations, structuring it in the medical record, and sending it to the Health Information System after the professional’s approval. This approach allows professionals to focus on the patient without the need to perform clinical documentation tasks. OBJECTIVE This study aims to evaluate patient-reported satisfaction and perceived quality of care, assess health care professionals’ satisfaction with the care provided, and measure the time spent on entering records into the electronic medical record using this AI-powered solution. METHODS This proof-of-concept (PoC) study is conducted as a multicenter trial with the participation of several health care professionals (nurses and physicians) in primary care centers (CAPs). The key outcome measures include (1) patient-reported quality of care (evaluated through anonymous surveys), (2) health care professionals’ satisfaction with the care provided (assessed through surveys and structured interviews), and (3) time saved on clinical documentation (determined by comparing the time spent manually writing notes versus reviewing and correcting AI-generated notes). Statistical analyses will be performed for each objective, using independent sample comparison tests according to normality evaluated with the Kolmogorov-Smirnov test and Lilliefors correction. Stratified statistical tests will also be performed to consider the variance between professionals. RESULTS The protocol has been developed using the SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) checklist. Recruitment began in July 2024, and as of November 2024, a total of 318 patients have been enrolled. Recruitment is expected to be completed by March 2025. Data analysis will take place between April and May 2025, with results expected to be published in June 2025. CONCLUSIONS We expect an improvement in the perceived quality of care reported by patients and a significant reduction in the time spent taking clinical notes, with a saving of at least 30 seconds per visit. Although a high quality of the notes generated is expected, it is uncertain whether a significant improvement over the control group, which is already expected to have high-quality notes, will be demonstrated. CLINICALTRIAL ClinicalTrials.gov NCT06618092; https://clinicaltrials.gov/study/NCT06618092 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/66232

19 January 2026 in Journal of Pharmaceutical Policy and Practice
Verified
Journal Article
Open access
CRC. Rovira
C. Rovira
MCM. Casanovas
M. Casanovas
EVE. Vizcaino
E. Vizcaino
MMM. Massanés
M. Massanés
QCQueralt Miró Catalina
Queralt Miró Catalina
PMPilar Modamio
Pilar Modamio
The person-centred care model involves a multidisciplinary team providing individualised health and social care aligned with patient preferences and health goals. Although some evidence supports its use in primary care, it remains under-evaluated. This study aimed to evaluate the effectiveness of a Collaborative Medication Management (CMM) approach in optimising pharmacotherapy plans versus usual care among polymedicated older adults. A randomised, open-label, multicentre, parallel clinical trial was conducted across 11 Primary Care Teams in Spain (Sept 2020–Jan 2024), including patients aged ≥75 years taking ≥8 chronic medications with complex or advanced conditions. The intervention group (IG, n = 102) received CMM delivered by a multidisciplinary team, including structured medication review, development of a patient-centred care plan, and follow-up at 6 and 12 months. The control group (CG, n = 106) received usual care. Primary outcomes were number of medications, drug-related prescriptions (DRP), changes to pharmacotherapy plans, and hospital admissions. Secondary outcomes included persistence of changes at 12 months and medication-related safety incidents. A total of 208 subjects were included (65.4% women; mean age 83.6 ± 6.3 years). IG showed a mean reduction of 1.8 ± 2.1 medications/patient vs. an increase of 0.3 ± 1.4 in CG (p = 0.004); a mean reduction of 2.9 ± 2.5 DRP/patient in IG vs. An increase of 0.2 ± 1.2 in CG (p = 0.004); a mean of 4.3 ± 2.9 changes to pharmacotherapy plans in IG vs. 2.6 ± 3.3 in CG (p = 0.004); a mean of 0.3 ± 0.7 hospital admissions in IG vs. 0.3 ± 0.8 in CG (p = 1.000). Persistence of changes at 12 months was 3.8 ± 2.7 in IG vs. 2.2 ± 2.9 in CG (p < 0.001). In addition, a mean of 0.5 ± 0.7 safety incidents was reported in IG vs. 0.5 ± 1.0 in CG (p = 0.676). The person-centred care model proved effect in optimising medication use in polymedicated older adults. Trial registration: ClinicalTrials.gov identifier: NCT04188470.